Will a new 2017 global leadership commit to NTDs?

PLoS Neglected Tropical Diseases
(Accessed 25 March 2017)

Will a new 2017 global leadership commit to NTDs?
Peter J. Hotez, Serap Aksoy
| published 23 Mar 2017 PLOS Neglected Tropical Diseases
Initial text
[In] 2017 we will experience a nearly wholesale shift in global governance as it relates to the world’s neglected tropical diseases (NTDs). A new United Nations (UN) Secretary General, Antonio Guterres from Portugal, was just appointed and we’ll soon have in place a new World Health Organization (WHO) Director General. In addition, the United States Government has so far been the largest financier of NTD mass drug administration (MDA), as well as research and development (R&D) for NTDs. A new US President, President Donald Trump, is now in the White House, while Prime Minister Theresa May has been appointed as the new British Prime Minister. The United Kingdom is probably the second largest global supporter of NTDs.
How shall we advocate? What does our community of NTD scientists, public health experts, and health care providers want this new global leadership to know about our diseases? What should they prioritize? Clearly, consensus on this front is problematic, but based on your submissions, emails, and letters, here are some early thoughts…